S. Gupta et al. / Tetrahedron Letters 51 (2010) 1887–1890
1889
Acknowledgment
R3
R4
O
NH
O2N
HO
NH
R4
R3
R
(i)
N
H
R
S.G. and P.K.A. are thankful to CSIR, New Delhi, India, for
fellowships.
NH2
NO2
7a-o
O
1a R = Ph,
6a R3 = H, R4 = H
References and notes
6b R3 = H, R4 = CH3
6c R3= OCH3, R4 = H
1b R = 4-OMe-Ph
1c R = 4-Me-Ph
1d R = 3-Me-Ph
1e R = CH3
(ii)
1. (a) Grimmett, M. R.. In Comprehensive Heterocyclic Chemistry; Katrizky, A. R.,
Rees, C. W., Scriven, E. F. V., Eds.; Pergamon: Oxford, 1996; 3, pp 77–220; (b)
Kim, J. S.; Gatto, B.; Yu, C.; Liu, L. F.; Lavoie, E. J. J. Med. Chem. 1996, 39, 992;
Greenhill, J. V.; Lue, L.. In Progress in Medicinal Chemistry; Ellis, G. P., Luscombe,
D. K., Eds.; Elsevier: New York, 1993; Vol. 3, (c) Erhardt, P. W. J. Med. Chem.
1987, 30, 231; (d) Tomczuk, B. E.; Taylor, C. R., Jr.; Moses, L. M.; Sutherland, D.
B.; Lo, Y. S.; Johnson, D. N.; Kinnier, W. B.; Kilpatrick, B. F. J. Med. Chem. 1991, 34,
2993; (e) LaPlante, S. R.; Jakalian, A.; Aubry, N.; Bousquet, Y.; Ferland, J.-M.;
Gillard, J.; Lefebvre, S.; Poirier, M.; Tsantrizos, Y. S.; Beaulieu, P. L. Angew. Chem.,
Int. Ed. 2004, 43, 4306; (f) Preston, P. N. Chem. Rev. 1974, 74, 279; (g) Spasov, A.
A.; Yozhitsa, I. N.; Bugaeva, L. I.; Anisimova, V. A. Pharm. Chem. J. 1999, 33, 232;
(h) Touzeau, F.; Arrault, A.; Guillaumet, G.; Scalbert, E.; Pfeiffer, B.; Rettori, M.-
C.; Renard, P.; Merour, J.-Y. J. Med. Chem. 2003, 46, 1962.
O
N
R4
R3
NH
R
8a-o
Scheme 2. Reagents and conditions: (i) DCC, HOBT, DMF, rt, 12 h; (ii) 10% Pd–C,
HCOONH4, CH3COOH, 80 °C, 1 h.
2. (a) Mhaske, S. B.; Argade, N. P. Tetrahedron 2006, 62, 9787; (b) Witt, A.;
Bergman, J. Curr. Org. Chem. 2003, 7, 659; (c) Connolly, D. J.; Cusack, D.;
O_Sullivan, T. P.; Guiry, P. J. Tetrahedron 2005, 61, 10153; (d) Ma, Z.; Hano, Y.;
Nomura, T. Heterocycles 2005, 65, 2203.
Table 3
Synthesis of quinazolinones 8a–o
3. (a) Brain, C. T.; Brunton, S. A. Tetrahedron Lett. 2002, 43, 1893; (b) Brain, C. T.;
Steer, J. T. J. Org. Chem. 2008, 71, 6814.
Entry
Substrate
R
R3
R4
Product
Yield (%)
4. Brasche, G.; Buchwald, S. L. Angew. Chem., Int. Ed. 2008, 47, 1932.
5. Yang, D.; Fu, H.; Hu, L.; Jiang, Y.; Zhao, Y. J. Org. Chem. 2008, 73, 7841.
6. Deng, X.; McAllister, H.; Mani, N. S. J. Org. Chem. 2009, 74, 5742.
7. Liu, X.; Fu, H.; Jiang, Y.; Zhao, Y. Angew. Chem., Int. Ed. 2009, 48, 348.
8. The mixture of benzenecarboximidamide (0.50 g, 4.11 mmol), 1-fluoro-2-
nitrobenzene (0.57 g, 4.11 mmol), and potassium carbonate (0.62 g,
4.52 mmol) in DMSO (5 ml) was taken in a microwave vial. The solution was
heated at 110 °C for 30 min in microwave (Biotage). The reaction mixture was
cooled to room temperature, water was added, and the compound was
extracted with ethyl acetate (15 mL Â 3). The organic layer was washed with
brine, dried over Na2SO4, and concentrated in vacuo to get the crude product
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
7a
7b
7c
7d
7e
7f
7g
7h
7i
7j
7k
7l
7m
7n
7o
C6H5–
C6H5–
C6H5–
H
H
OCH3
H
H
OCH3
H
H
OCH3
H
H
H
CH3
H
H
CH3
H
H
CH3
H
H
CH3
H
8a
8b
8c
8d
8e
8f
8g
8h
8i
8j
8k
8l
8m
8n
8o
96
91
95
97
92
96
91
95
93
94
91
94
93
95
96
4-(OCH3)–C6H4–
4-(OCH3)–C6H4–
4-(OCH3)–C6H4–
4-(CH3)–C6H4–
4-(CH3)–C6H4–
4-(CH3)–C6H4–
3-(CH3)–C6H4–
3-(CH3)–C6H4–
3-(CH3)–C6H4–
CH3
which was triturated with 9:1 hexane–diethyl ether to afford
compound which was used without further purification.
a yellow
OCH3
H
H
4-Methoxy-N-(5-methyl-2-nitrophenyl)benzene carboximidamide (3e): Yield =
0.87 g (92%), yellow oil, Rf = 0.48 (1:1 EtOAc–hexane), IR (KBr) mmax 2920,
H
CH3
H
CH3
CH3
1639, 1388, 1260 cmÀ1 1H NMR (300 MHz, CDCl3) d = 7.96–7.91 (1H, m, ArH),
;
OCH3
7.78 (2H, s, ArH), 6.98–6.93 (4H, m, ArH), 3.88 (3H, s, OCH3), 2.41 (3H, s, CH3);
13C NMR (50 MHz, CDCl3) d = 161.9, 145.7, 139.4, 129.8, 128.7, 127.6, 125.7,
124.8, 123.7, 114.3, 114.0, 55.5, 21.7; mass (ES+) m/z 286.1 (M++1); Anal. Calcd
for C15H15N3O3: C, 63.15; H, 5.30; N, 14.73. Found: C, 63.11; H, 5.28; N, 14.76.
9. To a stirred solution of N-(2-nitro-phenyl)-benzamidine (0.25 g, 1.04 mmol) in
acetic acid (2 ml) under nitrogen atmosphere were added ammonium formate
(0.40 g, 5.18 mmol) and palladium on carbon 10% wet (25 mg) at room
temperature. The reaction mixture was heated at 80 °C for 1 h. It was filtered
through Celite bed and washed with ethyl acetate. The filtrate was neutralized
with satd sodium bicarbonate. The compound was extracted with ethyl acetate
(15 mL Â 3). The organic layer was washed with brine, dried over Na2SO4, and
concentrated in vacuo. The crude product was triturated with 5:1 hexane–
diethyl ether to afford pure compound as white solid.
with aryl amidines (yield >90%) was more favored than that with ali-
phatic amidines (yield 51–53%). Next, for the transamination reac-
tion, the nitro group in the substrate 7a was subjected to reduction
with 10% Pd/C in AcOH using ammonium formate as a hydrogen do-
nor at 80 °C for 1 h. The resulting crude product obtained after work-
up was triturated with diethyl ether to furnish 2-phenylquinazolin-
4(3H)-one 8a12 in 96% isolated yield. Of the 15 quinazolinone deriv-
atives synthesized, physico-chemical parameters of 11 compounds
(8a–e, 8g–h, 8j, and 8m–o) matched with the ones reported in the
literature.7,13
The scope and limitation of our strategy were established by
synthesizing 14 compounds based on quinazolinone 8b–o (Table
3) using a variety of aromatic and aliphatic amidine-derived sub-
strates 7b–o and in all the cases the product was obtained in 91–
96% isolated yield after crystallization. In contrast, variable yields
of 40–87% were reported for quinazolinones from amidines in
the literature under copper-catalyzed conditions.7
In summary, we have developed a mild and efficient method
for the synthesis of highly substituted benzimidazole and qui-
nazolinone derivatives under catalyst and ligand-free conditions.
In general the strategy involves N-arylation and N-benzoylation
of amidines with o-nitro arenes followed by reduction of the ni-
tro group and intramolecular transamination reaction. The work-
up procedure was simple and isolation of the product without
column chromatography proved to be an added advantage for
the synthesis of benzimidazole and quinazolinone motifs. This
procedure will be a value addition for the synthesis of benzimid-
azole and quinazolinone derivatives of academic and industrial
importance.
2-Phenyl-1H-benzimidazole (5a): Yield = 0.19 g (96%), white solid, mp >250 °C
[lit.4 286–289], Rf = 0.48 (2:3 EtOAc–hexane), IR (KBr) mmax 3399, 1653, 1408,
1112 cmÀ1 1H NMR (300 MHz, DMSO-d6) d = 8.19–8.16 (2H, m, ArH), 7.61–
;
7.47 (5H, m, ArH), 7.23–7.18 (2H, m, ArH); 13C NMR (50 MHz, DMSO-d6)
d = 151.2, 130.1, 129.9, 128.9, 126.5, 122.1; mass (ES+) m/z 195.3 (M++1); Anal.
Calcd for C13H10N2: C, 80.39; H, 5.19; N, 14.42. Found: C, 80.43; H, 5.16; N,
14.41.
2-(4-Methylphenyl)-5-(trifluoromethyl)-1H-benzimidazole (5i): Yield = 0.19 g
(90%), white solid, mp 192–194 °C, Rf = 0.54 (2:3 EtOAc–hexane), IR (KBr)
m
max 3119, 1620, 1431, 1122 cmÀ1 1H NMR (300 MHz, DMSO-d6) d = 13.28 (1H,
;
s, NH), 8.13 (2H, d, J = 8.2 Hz, ArH), 7.96 (1H, s, ArH), 7.79 (1H, d, J = 8.4 Hz,
ArH), 7.56–7.54 (1H, m, ArH), 7.43 (2H, d, J = 8.0 Hz, ArH), 2.43 (3H, s, CH3);13
C
NMR (75 MHz, DMSO-d6) d = 154.1, 140.4, 129.6, 126.8, 122.8(d, J = 33.7 Hz),
122.4, 118.7, 20.9; mass (ES+) m/z 277.3 (M++1); Anal. Calcd for C15H11F3N2: C,
65.21; H, 4.01; N, 10.14. Found: C, 65.18; H, 4.00; N, 10.17.
10. (a) Lin, S.; Yang, L. Tetrahedron Lett. 2005, 46, 4315; (b) Lewis, J. C.; Wu, J. Y.;
Bergman, R. G.; Ellman, J. A. Angew. Chem., Int. Ed. 2006, 45, 1589; (c) Ji, Y.; Bur,
D.; Haesler, W.; Schmitt, V. R.; Dorn, A.; Bailly, C.; Waring, M. J.; Hochstrasser,
R.; Leupin, W. Bioorg. Med. Chem. 2001, 9, 2905; (d) Savall, B. M.; Fontimayor, J.
R. Tetrahedron Lett. 2008, 47, 6667; (e) Sharghi, H.; Beyzavi, M. H.;
Doroodmand, M. M. Eur. J. Org. Chem. 2008, 24, 4126; (f) Bougrin, K.;
Soufiaoui, M. Tetrahedron Lett. 1995, 36, 3683; (g) VanVliet, D. S.; Gillespie,
P.; Scicinski, J. J. Tetrahedron Lett. 2005, 46, 6741.
11. To a stirred solution of 2-nitrobenzoic acid (1.0 g, 6.66 mmol) in DMF (10 ml)
at 0 °C were added DCC (1.51 g, 7.33 mmol) and HOBT (0.99 g, 7.33 mmol) .The
reaction mixture was stirred at 0 °C for 1 h to which 4-methoxy-benzamidine
(1.22 g, 7.33 mmol) was added and allowed to stir at room temperature for
12 h. The reaction mixture was filtered through Celite bed and washed with
ethyl acetate. The filtrate was washed with brine, dried over Na2SO4, and